Email Print this page Bookmark this page

Aton Patient Savings Program

Save up to $60! Up to $20 off each of 3 prescription fills for TIMOPTIC® in OCUDOSE®.

Step 1: Enter your contact information below to receive a rebate for up to $20 off each of 3 prescription fills for TIMOPTIC® in OCUDOSE®. Select the box on the form below if you would also like to learn more about TIMOPTIC® in OCUDOSE®.

Aton Pharma will only use this information to send your rebate, unless you click the box on the form below indicating that you would like to receive free TIMOPTIC® in OCUDOSE® information.
Step 2: Once the information is submitted, press the button to view and print your rebate request form. Only 1 rebate is valid per prescription. The rebate will be in the amount of your co-pay, up to $20.
Zip Code*
Is this your first TIMOPTIC® in OCUDOSE® prescription?
If no, for how long have you been using TIMOPTIC® in OCUDOSE®?
Have you used a form of non–preservative-free timolol before?
* Indicates required information.
YES, I would like Aton Pharma, Inc. to send me periodic updates about TIMOPTIC® in OCUDOSE®.
Protecting Your Privacy
In order to provide you with a better Web site experience and better features in the future, we ask you for your e-mail address. If you provide this data, you agree to allow Aton Pharma, Inc. to link your e-mail address to anonymous (non−personally-identifiable) information that you may have given us previously, or that may have been collected on other Aton Pharma, Inc. Web sites. We will not sell your e-mail address, and you will not receive e-mail from us that you have not agreed to receive.

INDICATIONS AND USAGE

Preservative-free TIMOPTIC® in OCUDOSE® is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Preservative-free TIMOPTIC® in OCUDOSE® may be used when a patient is sensitive to the preservative in Timoptic (timolol maleate ophthalmic solution), benzalkonium chloride, or when use of a preservative-free topical medication is advisable.

IMPORTANT SAFETY INFORMATION

Timoptic is contraindicated in patients with: bronchial asthma; a history of bronchial asthma; severe chronic obstructive pulmonary disease; sinus bradycardia; second or third degree atrioventricular block; overt cardiac failure; cardiogenic shock; hypersensitivity to any component of this product.

This drug is absorbed systemically. The same adverse reactions found with systemic administration of beta-adrenergic blocking agents may occur with topical administration. Severe respiratory or cardiac reactions, including death, have been reported following systemic or ophthalmic administration of timolol maleate. Timoptic should be used with caution in patients with cerebrovascular insufficiency.

The most frequently reported adverse experiences have been burning and stinging upon instillation.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Prescribing Information important safety information instant coupon: up to $60 in savings Ocudose Form
© 2011 ATON Pharma, a Division of Valeant Pharmaceuticals
North America LLC. All Rights Reserved.